The analyses of tissue samples or genomic data sets from colon cancer patients mostly agree with the molecular outcome, that is, that high HIPK2 expression correlates with low Dukes stages and with high patient survival, suggesting that the HIPK2 presence is important in restraining tumor progression. The gene discussed is HIPK2; the disease is neoplasm.